Results 131 to 140 of about 577,522 (269)
Dermatologic Manifestations in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
The human T cell lymphotropic virus type-1 (HTLV-1) is associated with adult T cell leukemia/lymphoma (ATL) and other disorders, including a slowly progressive demyelinating paraparesis, known as HTLV-1-associated myelopathy/tropical spastic paraparesis (
Reza Boostani +8 more
doaj
Background Pentavalent antimonials (Sb5) are the first-line drugs for treating cutaneous leishmaniasis in Colombia; however, given problems with toxicity, compliance, availability, and cost, it is imperative to look for better therapeutic options ...
Liliana López +6 more
semanticscholar +1 more source
Cutaneous leishmaniasis in Iraq
To determine the incidence ofcutaneous leishmaniasis (CL) in Alhaweja District and to clarify the secondary bacterial infection inCL.A prospective survey was performed in the outpatient clinic of Alhaweja General Hospital. All the patients who presented at the dermatology clinic during the period from 1 October 2004 to the end of April 2005 were ...
Abdulghani Mohamad AlSamarai +1 more
openaire +4 more sources
Cutaneous leishmaniasis is the most common form of leishmaniasis and the available chemotherapy causes serious side effects, justifying the search for new therapies.
D. M. Casa +4 more
semanticscholar +1 more source
Cytodiagnosis of cutaneous leishmaniasis- a case report [PDF]
Leishmaniasis is endemic in many countries in tropical and subtropical regions. The diagnosis of cutaneous leishmaniasis on fine needle aspirates is unusual. Here, we report a case from non-endemic area of Rajasthan, in which aspiration cytology revealed
Ajay Gupta, Abha Patni +2 more
core +1 more source
Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea
Background Complex cutaneous and muco-cutaneous leishmaniasis (CL and MCL) often requires systemic therapy. Liposomal amphotericin B (L-AmB) has a strong potential for a solid clinical benefit in this indication.
R. Guery +15 more
semanticscholar +1 more source
Rifampicin in Cutaneous Leishmaniasis
A study is described which aimed at assessing the efficacy of rifampicin in the treatment of cutaneous leishmaniasis. A total of thirteen patients suffering from this condition were admitted to the study and were given rifampicin 600 mg daily. Three patients dropped out due to reasons unconnected with the trial and one patient left when the lesions ...
openaire +2 more sources
Presentation of AIDS with Disseminated Cutaneous and Visceral Leishmaniasis in Iran
Leishmaniasis is an infectious disease in form of visceral (VL), cutaneous (CL), and mucocutaneous (MCL) leishmaniasis. Immunocompromised patients have increased risk of Leishmania infection, especially in endemic areas for visceral leishmaniasis, where
Mohammadali Davarpanah +2 more
doaj +1 more source
Cutaneous leishmaniasis due to Leishmania braziliensis infection is an inflammatory disease which skin ulcer development is associated with mononuclear cells infiltrate and high levels of inflammatory cytokines production.
D. Santos +10 more
semanticscholar +1 more source

